查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026825

經皮貼片市場預測至2034年－按成分、應用、通路和地區分類的全球分析

Transdermal Skin Patches Market Forecasts to 2034 - Global Analysis By Component, By Application, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球經皮貼片市場預計到 2026 年將達到 99 億美元，並在預測期內以 6.6% 的複合年成長率成長，到 2034 年達到 165 億美元。

經皮貼片是醫療設備，旨在透過皮膚將藥物輸送到血液中。這些貼片由黏合劑層、藥物儲存和控制膜等多層結構組成，能夠控制藥物釋放並提供持續的藥物供應。貼於皮膚後，藥物無需經過消化器官系統即可直接被血液吸收。這為多種藥物提供了一種便捷、非侵入性的給藥方式，並可在較長時間內維持穩定的治療濃度。

根據 GLOBOCAN 2020 報告，2020 年墨西哥報告了 195,499 例癌症病例，其中乳癌和前列腺癌在人群中最為常見。

擴大口服和手動給藥的優勢

人們對經皮貼片的興趣日益濃厚，源自於其相較於口服藥物的顯著優勢。透皮貼片是一種非侵入性的消化器官系統，從而減少了胃腸道副作用。此外，透皮貼片能夠確保藥物的穩定可控釋放，維持穩定的治療濃度，進而提高病患的依從性。其給藥頻率低、使用方便，尤其適用於長期治療。更重要的是，經皮吸收貼片能夠減輕藥物在胃腸道分解帶來的問題，提高生物利用度，使其成為傳統口服藥物的極具前景的替代方案。

品牌知名度低，產品成本高

經皮貼片認知度低和產品成本高是主要的阻礙因素。消費者和醫療專業人員對其益處和應用了解不足，會阻礙其推廣應用。此外，這些貼片的配方和生產成本高昂，導致市場價格偏高，影響部分患者的用藥。這些因素共同阻礙了透皮貼片的廣泛應用和普及，限制了這種高效給藥系統在多種疾病治療中的應用潛力。

處方經皮吸收貼片的需求日益成長。

處方箋經皮貼片需求的不斷成長為經皮貼片市場帶來了巨大的機會。這種需求的激增反映了人們對非口服給藥方式的偏好轉變以及對患者便利性的日益重視。個人化醫療和標靶治療的興起也增加了對專用處方箋貼片的需求。這也推動了貼片技術改進、治療方案拓展以及經皮給藥市場成長的研究。

皮膚吸收各種活性成分的能力是有限的。

選擇性皮膚滲透性是經皮吸收貼片面臨的一大挑戰，因為並非所有物質都能有效穿透皮膚屏障。這項限制縮小了適用於經皮給藥的藥物範圍，並阻礙了特異性治療方法的研發。此外，聚合物、親水性化合物以及具有某些特定化學性質的物質難以有效穿過皮膚屏障，進一步限制了適用於經皮給藥的物質範圍。

新冠疫情的影響：

新冠疫情對經皮貼片市場產生了重大影響。儘管某些用於緩解疼痛和荷爾蒙療法的貼片需求保持穩定，但供應鏈中斷和醫療服務取得受阻影響，進而影響了生產和分銷。封鎖措施也影響了患者就診，可能阻礙了新處方的處方箋和貼劑使用者的常規檢查。然而，疫情凸顯了非侵入性給藥方式的重要性，並可能在未來推動經皮吸收貼片的進一步創新和應用。

在預測期內，「含藥黏合劑」細分市場預計將成為最大的細分市場。

由於其諸多優勢，預計「含藥黏合劑」細分市場將在預測期內佔據主導地位。含藥黏合劑貼片透過將藥物直接摻入黏合層，確保精準的劑量和與皮膚的良好黏合。這種設計具有便利、易於應用和藥物穩定釋放的優點。此外，它還能最大限度地降低意外脫落的風險。憑藉其簡單易用的應用方法和可靠的藥物釋放特性，含藥黏合劑貼片有望繼續保持其市場優勢，並進一步鞏固其市場地位。

在預測期內，醫院藥房細分市場預計將呈現最高的複合年成長率。

受多種因素影響，醫院藥房市場預計將迎來顯著成長。醫院在患者照護中扮演著至關重要的角色，也是包括經皮貼片在內的藥品的主要供應中心。需要長期用藥的慢性病盛行率不斷上升，加之經皮給藥系統的日益普及，正在推動醫院藥局對透皮貼片的需求。此外，患者能夠在醫院內便捷地取得和使用透皮貼劑，也促進了該市場預計的顯著成長。

市佔率最大的地區：

北美地區擁有先進的醫療保健基礎設施、高額的醫療保健支出，並高度重視藥物輸送系統領域的技術進步，預計將成為經皮貼片市場的主要驅動力。此外，慢性病患者人數不斷成長的老年人口以及文明病的日益普遍，也推動了對經皮貼片的需求。同時，完善的法規結構和主要市場參與者的強大影響力，也預計將鞏固北美地區的市場主導地位。

複合年成長率最高的地區：

由於人口成長、健康意識提高以及慢性病盛行率上升，亞太地區的經皮貼片市場預計將顯著成長。此外，醫療基礎設施的改善、非侵入性治療的普及以及新興經濟體推動醫療進步，也促進了亞太地區透皮貼劑市場的蓬勃發展。同時，政府的支持措施和對改善醫療服務可近性的重視，也進一步推動了該地區市場的擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章：全球經皮貼片市場：依成分分類

  • 水庫
  • 含藥黏合劑
    • 單層
    • 多層型
  • 矩陣
  • 微型針
  • 其他規則

第6章：全球經皮貼片市場：依應用領域分類

  • 疼痛管理
  • 心血管疾病
  • 中樞神經系統疾病
  • 荷爾蒙療法
  • 神經系統疾病
  • 禁止抽煙
  • 膀胱過動症
  • 其他用途

第7章：全球經皮貼片市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章：全球經皮貼片市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • 4P Therapeutics
  • AdhexPharma
  • Aveva Drug Delivery Systems
  • Bayer AG
  • Corium, LLC
  • GlaxoSmithKline（GSK）
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Luye Pharma Group
  • Mundipharma
  • Mylan NV
  • Nitto Denko Corporation
  • Novartis
  • Pfizer Inc.
  • Praj HiPurity Systems Limited
  • ProSolus Pharmaceuticals
  • Sorrento Therapeutics Inc
  • Teva Pharmaceuticals
  • TheraDep Technologies
  • Transdermal Delivery Solutions Corporation
Product Code: SMRC24661

According to Stratistics MRC, the Global Transdermal Skin Patches Market is accounted for $9.9 billion in 2026 and is expected to reach $16.5 billion by 2034 growing at a CAGR of 6.6% during the forecast period. Transdermal skin patches are medical devices designed to deliver medication through the skin and into the bloodstream. Comprising layers including an adhesive, drug reservoir and a controlling membrane, these patches offer controlled, continuous drug release. They adhere to the skin, allowing drugs to be absorbed directly into circulation, bypassing the digestive system. They provide a convenient, non-invasive delivery method for various medications, maintaining steady therapeutic levels over time.

According to the GLOBOCAN 2020 report, 195,499 cancer cases were reported in Mexico in 2020, with breast and prostate cancers being the most common among the population.

Market Dynamics:

Driver:

Increasing advantages over the oral and ingesting medications

The rising preference for transdermal skin patches is fueled by their distinct advantages over oral medication. These patches offer non-invasive drug delivery, bypassing the digestive system and reducing gastrointestinal side effects. They ensure a steady, controlled release of medication, maintain consistent therapeutic levels and enhance patient compliance. With fewer dosing frequencies and simplified application, they provide convenience, especially for long-term therapies. Additionally, transdermal patches mitigate issues related to drug degradation in the digestive tract, improving bioavailability and offering a promising alternative to traditional oral medications.

Restraint:

Lack of awareness and elevated product costs

The limited awareness surrounding transdermal skin patches and their higher product costs pose significant restraints. Insufficient knowledge among consumers and healthcare professionals about their benefits and applications may limit their adoption. Moreover, elevated production expenses involved in formulating and manufacturing these patches contribute to higher market prices, impacting accessibility for some patients. These combined factors hinder widespread acceptance and affordability, impeding the potential utilization of this effective drug delivery system for various medical conditions.

Opportunity:

Growing need for prescription transdermal patches

The increasing demand for prescription transdermal patches presents a significant opportunity in the transdermal skin patch market. This surge reflects evolving preferences for non-oral drug delivery methods and a growing emphasis on patient convenience. With a shift toward personalized medicine and targeted therapies, the need for specialized, prescription-based patches is rising. It also fuels research into enhanced patch technologies, expanding treatment options and driving market growth in the transdermal medication sector.

Threat:

Skin's limited capacity to absorb various active substances

The skin's selective permeability poses a challenge for transdermal patches, as not all substances can effectively penetrate its barriers. This limitation restricts the range of medications suitable for transdermal delivery, hindering the development of certain therapies. Additionally, large molecules, hydrophilic compounds and those with specific chemical properties struggle to traverse the skin barrier effectively, limiting the range of substances suitable for transdermal delivery.

Covid-19 Impact:

The COVID-19 pandemic has significantly influenced the transdermal skin patches market. While demand for certain patches, like those delivering pain relief or hormone therapies, remained steady, disruptions in supply chains and healthcare access impacted production and distribution. Lockdowns also affected patient consultations, potentially hindering new prescriptions and routine check-ups for patch users. However, the pandemic underscored the significance of non-invasive drug delivery methods, potentially driving further innovation and adoption of transdermal patches in the future.

The drug-in-adhesive segment is expected to be the largest during the forecast period

The drug-in-adhesive segment is expected to dominate the market during the forecast period due to its advantages. Drug-in-adhesive patches integrate the drug directly into the adhesive layer, ensuring precise dosing and enhanced skin contact. This design offers convenience, simplicity in application, and consistent drug delivery. Moreover, it minimizes the risk of accidental detachment. With its user-friendly application and reliable drug release profile, the drug-in-adhesive patch is anticipated to remain the preferred choice, fostering its prominence in the market.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is poised for significant growth due to various factors. Hospitals play a pivotal role in patient care and are key distribution points for pharmaceuticals, including transdermal patches. The increasing prevalence of chronic diseases requiring long-term medication, coupled with the rising adoption of transdermal drug delivery systems, is driving demand in hospital pharmacies. Additionally, the convenience of obtaining and administering patches within a hospital setting contributes to the projected substantial growth of the market.

Region with largest share:

North America is anticipated to lead the transdermal skin patches market due to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on technological advancements in drug delivery systems. Additionally, a growing elderly population with chronic conditions, coupled with the prevalence of lifestyle-related diseases, fuels the demand for transdermal patches. Moreover, supportive regulatory frameworks and a strong presence of key market players contribute to North America's anticipated dominance.

Region with highest CAGR:

Asia Pacific is poised for notable growth in the transdermal skin patches market owing to the region's expanding population, rising healthcare awareness and increasing prevalence of chronic diseases. Moreover, improving healthcare infrastructure, a shift towards non-invasive treatments, and the presence of emerging economies fostering healthcare advancements contribute to the projected substantial growth in Asia Pacific. Additionally, supportive government initiatives and a focus on enhancing healthcare accessibility further propel market expansion in this region.

Key players in the market

Some of the key players in transdermal skin patches market include 4P Therapeutics, AdhexPharma, Aveva Drug Delivery Systems, Bayer AG, Corium, LLC, GlaxoSmithKline (GSK), Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Luye Pharma Group, Mundipharma, Mylan N.V., Nitto Denko Corporation, Novartis, Pfizer Inc., Praj HiPurity Systems Limited, ProSolus Pharmaceuticals, Sorrento Therapeutics Inc, Teva Pharmaceuticals, TheraDep Technologies and Transdermal Delivery Solutions Corporation.

Key Developments:

In April 2023, researchers at MIT University developed a wearable patch that enables painless skin patch delivery. The patch utilizes painless ultrasonic waves to create tiny channels, allowing drugs to pass through the tough outer layer of the skin. This innovative approach holds the potential for delivering treatments for various skin conditions. This patch can also be adapted for delivering muscle relaxants, hormones, and other drugs.

In September 2022, Corium launched its Adlarity (donepezil transdermal system) for prescription use in the US Adlarity, a once-weekly patch, delivers consistent doses of donepezil through the skin. It could treat patients with mild, moderate, or severe dementia of Alzheimer's type.

In April 2022, Luye Pharma Group announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) had accepted the Marketing Authorization Application (MAA) for the company's investigational Rivastigmine Twice Weekly Transdermal Patch that was indicated for treating Alzheimer's disease of mild to moderate symptoms.

Components Covered:

  • Reservoir
  • Drug-in-Adhesive
  • Matrix
  • Microneedle
  • Other Components

Applications Covered:

  • Pain Management
  • Cardiovascular Disorders
  • Central Nervous System Disorders
  • Hormonal Therapy
  • Neurological Disorders
  • Nicotine Cessation
  • Overactive Bladder
  • Other Applications

Distribution Channels Covered:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Skin Patches Market, By Component

  • 5.1 Introduction
  • 5.2 Reservoir
  • 5.3 Drug-in-Adhesive
    • 5.3.1 Single Layer
    • 5.3.2 Multilayer
  • 5.4 Matrix
  • 5.5 Microneedle
  • 5.6 Other Components

6 Global Transdermal Skin Patches Market, By Application

  • 6.1 Introduction
  • 6.2 Pain Management
  • 6.3 Cardiovascular Disorders
  • 6.4 Central Nervous System Disorders
  • 6.5 Hormonal Therapy
  • 6.6 Neurological Disorders
  • 6.7 Nicotine Cessation
  • 6.8 Overactive Bladder
  • 6.9 Other Applications

7 Global Transdermal Skin Patches Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Online Pharmacies
  • 7.4 Retail Pharmacies

8 Global Transdermal Skin Patches Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 4P Therapeutics
  • 10.2 AdhexPharma
  • 10.3 Aveva Drug Delivery Systems
  • 10.4 Bayer AG
  • 10.5 Corium, LLC
  • 10.6 GlaxoSmithKline (GSK)
  • 10.7 Hisamitsu Pharmaceutical Co., Inc.
  • 10.8 Johnson & Johnson
  • 10.9 Luye Pharma Group
  • 10.10 Mundipharma
  • 10.11 Mylan N.V.
  • 10.12 Nitto Denko Corporation
  • 10.13 Novartis
  • 10.14 Pfizer Inc.
  • 10.15 Praj HiPurity Systems Limited
  • 10.16 ProSolus Pharmaceuticals
  • 10.17 Sorrento Therapeutics Inc
  • 10.18 Teva Pharmaceuticals
  • 10.19 TheraDep Technologies
  • 10.20 Transdermal Delivery Solutions Corporation

List of Tables

  • Table 1 Global Transdermal Skin Patches Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Transdermal Skin Patches Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Transdermal Skin Patches Market Outlook, By Reservoir (2023-2034) ($MN)
  • Table 4 Global Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2023-2034) ($MN)
  • Table 5 Global Transdermal Skin Patches Market Outlook, By Single Layer (2023-2034) ($MN)
  • Table 6 Global Transdermal Skin Patches Market Outlook, By Multilayer (2023-2034) ($MN)
  • Table 7 Global Transdermal Skin Patches Market Outlook, By Matrix (2023-2034) ($MN)
  • Table 8 Global Transdermal Skin Patches Market Outlook, By Microneedle (2023-2034) ($MN)
  • Table 9 Global Transdermal Skin Patches Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 10 Global Transdermal Skin Patches Market Outlook, By Application (2023-2034) ($MN)
  • Table 11 Global Transdermal Skin Patches Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 12 Global Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 13 Global Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2023-2034) ($MN)
  • Table 14 Global Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2023-2034) ($MN)
  • Table 15 Global Transdermal Skin Patches Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 16 Global Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2023-2034) ($MN)
  • Table 17 Global Transdermal Skin Patches Market Outlook, By Overactive Bladder (2023-2034) ($MN)
  • Table 18 Global Transdermal Skin Patches Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 19 Global Transdermal Skin Patches Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 20 Global Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 21 Global Transdermal Skin Patches Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 22 Global Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 23 North America Transdermal Skin Patches Market Outlook, By Country (2023-2034) ($MN)
  • Table 24 North America Transdermal Skin Patches Market Outlook, By Component (2023-2034) ($MN)
  • Table 25 North America Transdermal Skin Patches Market Outlook, By Reservoir (2023-2034) ($MN)
  • Table 26 North America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2023-2034) ($MN)
  • Table 27 North America Transdermal Skin Patches Market Outlook, By Single Layer (2023-2034) ($MN)
  • Table 28 North America Transdermal Skin Patches Market Outlook, By Multilayer (2023-2034) ($MN)
  • Table 29 North America Transdermal Skin Patches Market Outlook, By Matrix (2023-2034) ($MN)
  • Table 30 North America Transdermal Skin Patches Market Outlook, By Microneedle (2023-2034) ($MN)
  • Table 31 North America Transdermal Skin Patches Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 32 North America Transdermal Skin Patches Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 North America Transdermal Skin Patches Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 34 North America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 35 North America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2023-2034) ($MN)
  • Table 36 North America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2023-2034) ($MN)
  • Table 37 North America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 38 North America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2023-2034) ($MN)
  • Table 39 North America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2023-2034) ($MN)
  • Table 40 North America Transdermal Skin Patches Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 41 North America Transdermal Skin Patches Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 42 North America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 43 North America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 44 North America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 45 Europe Transdermal Skin Patches Market Outlook, By Country (2023-2034) ($MN)
  • Table 46 Europe Transdermal Skin Patches Market Outlook, By Component (2023-2034) ($MN)
  • Table 47 Europe Transdermal Skin Patches Market Outlook, By Reservoir (2023-2034) ($MN)
  • Table 48 Europe Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2023-2034) ($MN)
  • Table 49 Europe Transdermal Skin Patches Market Outlook, By Single Layer (2023-2034) ($MN)
  • Table 50 Europe Transdermal Skin Patches Market Outlook, By Multilayer (2023-2034) ($MN)
  • Table 51 Europe Transdermal Skin Patches Market Outlook, By Matrix (2023-2034) ($MN)
  • Table 52 Europe Transdermal Skin Patches Market Outlook, By Microneedle (2023-2034) ($MN)
  • Table 53 Europe Transdermal Skin Patches Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 54 Europe Transdermal Skin Patches Market Outlook, By Application (2023-2034) ($MN)
  • Table 55 Europe Transdermal Skin Patches Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 56 Europe Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 57 Europe Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2023-2034) ($MN)
  • Table 58 Europe Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2023-2034) ($MN)
  • Table 59 Europe Transdermal Skin Patches Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 60 Europe Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2023-2034) ($MN)
  • Table 61 Europe Transdermal Skin Patches Market Outlook, By Overactive Bladder (2023-2034) ($MN)
  • Table 62 Europe Transdermal Skin Patches Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 63 Europe Transdermal Skin Patches Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 64 Europe Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 65 Europe Transdermal Skin Patches Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 66 Europe Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 67 Asia Pacific Transdermal Skin Patches Market Outlook, By Country (2023-2034) ($MN)
  • Table 68 Asia Pacific Transdermal Skin Patches Market Outlook, By Component (2023-2034) ($MN)
  • Table 69 Asia Pacific Transdermal Skin Patches Market Outlook, By Reservoir (2023-2034) ($MN)
  • Table 70 Asia Pacific Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2023-2034) ($MN)
  • Table 71 Asia Pacific Transdermal Skin Patches Market Outlook, By Single Layer (2023-2034) ($MN)
  • Table 72 Asia Pacific Transdermal Skin Patches Market Outlook, By Multilayer (2023-2034) ($MN)
  • Table 73 Asia Pacific Transdermal Skin Patches Market Outlook, By Matrix (2023-2034) ($MN)
  • Table 74 Asia Pacific Transdermal Skin Patches Market Outlook, By Microneedle (2023-2034) ($MN)
  • Table 75 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 76 Asia Pacific Transdermal Skin Patches Market Outlook, By Application (2023-2034) ($MN)
  • Table 77 Asia Pacific Transdermal Skin Patches Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 78 Asia Pacific Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 79 Asia Pacific Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2023-2034) ($MN)
  • Table 80 Asia Pacific Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2023-2034) ($MN)
  • Table 81 Asia Pacific Transdermal Skin Patches Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 82 Asia Pacific Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2023-2034) ($MN)
  • Table 83 Asia Pacific Transdermal Skin Patches Market Outlook, By Overactive Bladder (2023-2034) ($MN)
  • Table 84 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 85 Asia Pacific Transdermal Skin Patches Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 86 Asia Pacific Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 87 Asia Pacific Transdermal Skin Patches Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 88 Asia Pacific Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 89 South America Transdermal Skin Patches Market Outlook, By Country (2023-2034) ($MN)
  • Table 90 South America Transdermal Skin Patches Market Outlook, By Component (2023-2034) ($MN)
  • Table 91 South America Transdermal Skin Patches Market Outlook, By Reservoir (2023-2034) ($MN)
  • Table 92 South America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2023-2034) ($MN)
  • Table 93 South America Transdermal Skin Patches Market Outlook, By Single Layer (2023-2034) ($MN)
  • Table 94 South America Transdermal Skin Patches Market Outlook, By Multilayer (2023-2034) ($MN)
  • Table 95 South America Transdermal Skin Patches Market Outlook, By Matrix (2023-2034) ($MN)
  • Table 96 South America Transdermal Skin Patches Market Outlook, By Microneedle (2023-2034) ($MN)
  • Table 97 South America Transdermal Skin Patches Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 98 South America Transdermal Skin Patches Market Outlook, By Application (2023-2034) ($MN)
  • Table 99 South America Transdermal Skin Patches Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 100 South America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 101 South America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2023-2034) ($MN)
  • Table 102 South America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2023-2034) ($MN)
  • Table 103 South America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 104 South America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2023-2034) ($MN)
  • Table 105 South America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2023-2034) ($MN)
  • Table 106 South America Transdermal Skin Patches Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 107 South America Transdermal Skin Patches Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 108 South America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 109 South America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 110 South America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 111 Middle East & Africa Transdermal Skin Patches Market Outlook, By Country (2023-2034) ($MN)
  • Table 112 Middle East & Africa Transdermal Skin Patches Market Outlook, By Component (2023-2034) ($MN)
  • Table 113 Middle East & Africa Transdermal Skin Patches Market Outlook, By Reservoir (2023-2034) ($MN)
  • Table 114 Middle East & Africa Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2023-2034) ($MN)
  • Table 115 Middle East & Africa Transdermal Skin Patches Market Outlook, By Single Layer (2023-2034) ($MN)
  • Table 116 Middle East & Africa Transdermal Skin Patches Market Outlook, By Multilayer (2023-2034) ($MN)
  • Table 117 Middle East & Africa Transdermal Skin Patches Market Outlook, By Matrix (2023-2034) ($MN)
  • Table 118 Middle East & Africa Transdermal Skin Patches Market Outlook, By Microneedle (2023-2034) ($MN)
  • Table 119 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 120 Middle East & Africa Transdermal Skin Patches Market Outlook, By Application (2023-2034) ($MN)
  • Table 121 Middle East & Africa Transdermal Skin Patches Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 122 Middle East & Africa Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 123 Middle East & Africa Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2023-2034) ($MN)
  • Table 124 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2023-2034) ($MN)
  • Table 125 Middle East & Africa Transdermal Skin Patches Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 126 Middle East & Africa Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2023-2034) ($MN)
  • Table 127 Middle East & Africa Transdermal Skin Patches Market Outlook, By Overactive Bladder (2023-2034) ($MN)
  • Table 128 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 129 Middle East & Africa Transdermal Skin Patches Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 130 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 131 Middle East & Africa Transdermal Skin Patches Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 132 Middle East & Africa Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2023-2034) ($MN)